Maravai Lifesciences Holdings (MRVI) Operating Expenses (2020 - 2026)

Maravai Lifesciences Holdings' Operating Expenses history runs 7 years deep, the most recent figure standing at $35.9 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 36.96% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $267.9 million (down 32.13% YoY), while the FY2025 annual figure was $249.3 million, down 27.53% from the prior year.
• Operating Expenses was $35.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $71.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $197.8 million in Q3 2024 to a low of -$67.5 million in Q4 2023.
• Historically, Operating Expenses has averaged $72.1 million across 5 years, with a median of $76.5 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 170.65% in 2023, then jumped 184.64% in 2024.
• A 5-year view of Operating Expenses shows it stood at $95.5 million in 2022, then slumped by 170.65% to -$67.5 million in 2023, then surged by 184.64% to $57.1 million in 2024, then increased by 25.48% to $71.6 million in 2025, then plunged by 49.94% to $35.9 million in 2026.
• The last three Operating Expenses figures came in at $35.9 million (Q1 2026), $71.6 million (Q4 2025), and $46.7 million (Q3 2025), per Business Quant data.